Cardiol Therapeutics Inc. (CRDL) stock
CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.86−0.02 (-2.28%)
Close on Nov 20, 2026Market cap $86.48MP/E –Yield –
Cardiol Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 87M, up 21.5% from the year before. The highest annual figure on record is 87M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 87M | +21.5% |
| FY2024 | Dec 31, 2024 | 72M | +11.0% |
| FY2023 | Dec 31, 2023 | 64M | +3.1% |
| FY2022 | Dec 31, 2022 | 63M | +44.6% |
| FY2021 | Dec 31, 2021 | 43M | +44.8% |
| FY2020 | Dec 31, 2020 | 30M | – |
See a number that looks wrong?